öλÔÓéÀֵǼÈë¿ÚÏÂÔØ

µ¼Ê¦ÐÕÃû£ºÐÜÑà
ÐÔ±ð£ºÅ®
ÈËÆøÖ¸Êý£º49

ËùÊôԺУ£º¹ãÖÝÒ½¿Æ´óѧ
ËùÊôԺϵ£º
Ö°³Æ£º¸±½ÌÊÚ
µ¼Ê¦ÀàÐÍ£ºË¶µ¼
ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÒ©Àíѧ


ͨѶ·½Ê½ :
°ì¹«µç»°£º**
µç×ÓÓʼþ£ºxiongyan2007@yahoo.com


¸öÈ˼òÊö :
ÐÜ Ñ࣬Ů£¬Ãñ¸ïµ³Ô±£¬Ò½Ñ§²©Ê¿£¬Ò©Àíѧ½ÌÊÚ£¬²©Ê¿Ñо¿Éúµ¼Ê¦¡£1996Äê10ÔÂÖÁ1998Äê9Ô£¬ÔÚÏã¸Û´óѧÉúÀí¡¢ÄÚ¿Æѧϵ¿ÆÑнøÐÞ£»2004Äê9ÔÂÖÁ2007Äê4Ô£¬¸°ÃÀ¹ú±±¿¨Hamner½¡¿µ¿ÆѧÑо¿Ëù´Óʲ©Ê¿ºóÑо¿¡£×Ô1982Äê´óѧ±ÏÒµºóÒ»Ö±´ÓÊÂÒ©Àíѧ½Ìѧ¹¤×÷£»×Ô1992Äê˶ʿÑо¿Éú±ÏÒµºóÒ»Ö±ÁôÔÚÖÐÄÏ´óѧÏæÑÅҩѧԺҩÀíѧϵ´ÓÊ¡°Ò»Ñõ»¯µªºÏøÒÖÖÆÎï¶þ¼×»ù¾«°±ËᣨADMA£©ÔÚ¶¯ÂöÖàÑùÓ²»¯ºÍÌÇÄò²¡Ñª¹Ü²¢·¢Ö¢ÖеÄ×÷Óü°Æä»úÖÆÓëÒ©Îï¡¢»ùÒò¸ÉÔ¤¡±Ñо¿ºÍÒ©Àíѧ½Ìѧ¹¤×÷£¬¾ßÓÐÎȶ¨µÄ¿ÆÑз½Ïò¡£ÔÚ¸ÃÁìÓòËĴλñ¹ú¼Ò×ÔÈ»¿Æѧ»ù½ð×ÊÖú£¬Ò»´Î»ñÎÀÉú²¿ÓÅÐãÇàÄê¿Æ¼¼È˲Żù½ð×ÊÖú£»ÏȺó»ñºþÄÏÊ¡¿Æ¼¼½ø²½¶þµÈ½±£¨µÚ¶þÍê³ÉÈË£¬»ñ½±ÏîÄ¿±àºÅ£º960134£©¡¢ÎÀÉú²¿¿Æ¼¼½ø²½¶þµÈ½±£¨µÚ¶þÍê³ÉÈË£¬»ñ½±Ö¤Êé±àºÅ£º**£©¡¢ºþÄÏÊ¡Ò½Ò©¿Æ¼¼³É¹ûÒ»µÈ½±£¨µÚÒ»Íê³ÉÈË£¬»ñ½±Ö¤Êé±àºÅ£º**£©¡¢ºþÄÏÊ¡×ÔÈ»¿Æѧ½±¶þµÈ½±£¨µÚÒ»Íê³ÉÈË£¬»ñ½±Ö¤Êé±àºÅ£º**-018-R01£©¡£ÒѲμӹú¼ÊѧÊõ»áÒéºÍÈ«¹úÒ©ÀíѧÊõ´ó»á¸÷10Óà´Î£¬·¢±íѧÊõÂÛÎÄ50Óàƪ£¬ÆäÖÐ50%ÒÔÉÏ·¢±íÔÚSCIÊÕ¼ÆÚ¿¯¡£1995Äê½úÉýΪҩÀíѧ¸±½ÌÊÚ£¬1996ÄêåàѡΪ˶ʿÑо¿Éúµ¼Ê¦£»2000Äê½úÉýΪҩÀíѧ½ÌÊÚ£¬Í¬Äê¹¥¶ÁÖÐÄÏ´óѧҩÀíѧÔÚÖ°²©Ê¿Ñо¿Éú£¬Ê¦´ÓÎÒ¹úÖøÃûµÄÁÙ´²Ò©Àíѧ¼ÒÖܺêå°ÔºÊ¿£»2002ÄêÈëѡΪºþÄÏÊ¡¸ßµÈѧУѧ¿Æ´øÍ·ÈËÅàÑø¶ÔÏó£¬2003Äê»ñ²©Ê¿Ñ§Î»£¬2004ÄêåàѡΪ²©Ê¿Ñо¿Éúµ¼Ê¦£¬2005Ä꿪ʼÕÐÊÕ²©Ê¿Ñо¿Éú£¬²¢ÈëÑ¡ºþÄÏÊ¡ÐÂÊÀ¼Í121È˲Ź¤³ÌÈËÑ¡£»ÒÑÕÐÊÕ˶¡¢²©Ê¿Ñо¿Éú21ÈË£¬±ÏÒµ15ÈË£¬ÆäÖÐÈýÈË»ñºþÄÏÊ¡ÓÅÐã˶ʿѧλÂÛÎÄ¡£×÷Ϊ¸±Ö÷±àºÍ±àί²ÎÓëÁËÆß±¾×¨ÖøºÍ½Ì²ÄµÄ±àд£»²¢µ£ÈκþÄÏÊ¡²¡ÀíÉúÀíѧ»á³£ÎñÀíÊ¡¢ºþÄÏÊ¡²¡ÀíÉúÀíѧ»áÐÄѪ¹ÜöλÔÓéÀֵǼÈë¿ÚÏÂÔØίԱ»á¸±Ö÷ÈÎίԱ¡¢ÖйúÐÄѪ¹ÜÒ©ÀíѧöλÔÓéÀֵǼÈë¿ÚÏÂÔØίԱ»áίԱ£¬ÒÔ¼°ºþÄÏÊ¡×ÛºÏÆÀ±êר¼Ò£¬ºþÄÏÊ¡Ò©Æ·ÆÀÉóר¼Ò¡¢¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðÏîÄ¿ÆÀÉóר¼Ò¡¢¹ú¼Ò¿Æ¼¼²¿¹ú¼ÊºÏ×÷¼Æ»®ÏîÄ¿ÆÀÉóר¼ÒµÈѧÊõ¼æÖ°¡£2010Äê×÷ΪÈ˲ÅÒý½øÀ´¹ãÖÝҽѧԺ»ù´¡Ñ§Ôº¹¤×÷£¬ÈιãÖÝҽѧԺҩÀíѧ½ÌÊÚ¡¢²©Ê¿ºÍ˶ʿÑо¿Éúµ¼Ê¦¡¢Ñª¹ÜÒ©ÀíÑо¿·½Ïòѧ¿Æ´øÍ·ÈË¡¢É߶¾Ñо¿ËùËù³¤¡£Ä¿Ç°Ö÷ÒªÑо¿ÄÚÔ´ÐÔÒ»Ñõ»¯µªºÏøÒÖÖÆÎïADMAÔÚÌÇÄò²¡Ðļ¡¡¢¹Ç÷À¼¡ºÍ¸ÎÔàÏßÁ£Ì幦ÄÜÕÏ°­ÓëÄÚÖÊÍøÓ¦¼¤ÖеÄ×÷Óü°Æä»úÖÆÒÔ¼°É߶¾¶ÔÐļ¡¡¢¹Ç÷À¼¡ºÍ¸ÎÔàÌÇ¡¢Ö¬´úлµÄÓ°Ïì¡£

¿ÆÑй¤×÷ :
´ú±íÐÔSCIÂÛÎÄ£º
1) Chen N, Leng YP, Xu WJ, Luo JD, Chen MS, Xiong Y (ÐÜÑ࣬ͨѶ×÷Õß). Contribution of endogenous inhibitor of nitric oxide synthase to hepatic mitochondrial dysfunction in streptozotocin-induced diabetic rats. Cell Physiol Biochem. 2011 27(3-4): 341-352.2) Feng M, He ZM, Zhu YX, Liu LH, Lu CW, Xiong Y (ÐÜÑ࣬ͨѶ×÷Õß). Improvement of endothelial dysfunction in atherosclerotic rabbit aortas by ex vivo gene transferring of dimethylarginine dimethylaminohydrolase-2. Int J Cardiol. 2010 144:180-186.3) Lu CW, Guo Z, Feng M, Wu ZZ, He ZM, Xiong Y (ÐÜÑ࣬ͨѶ×÷Õß). Ex vivo gene transferring of human dimethylarginine dimethylaminohydrolase-2 improved endothelial dysfunction in diabetic rat aortas and high glucose-treated endothelial cells. Atherosclerosis 2010 209(1): 66-73.4) Feng M, Liu LH, Guo Z, Xiong Y (ÐÜÑ࣬ͨѶ×÷Õß). Gene transfer of dimethylarginine dimethylaminohydrolase-2 improves the impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells induced by lysophosphatidylcholine. Eur J Pharmacol 2008 584(1): 49-56.5) Xiong Y(ÐÜÑà). Overexpression of dimethylarginine dimethylaminohydrolase-2 reverses endothelial dysfunction in diabetic rat aortas. Circulation 2008 118 (Suppl 1): S366.6) Yin QF, Fu SH, He P, Xiong Y (ÐÜÑ࣬ͨѶ×÷Õß). Dimethylarginine dimethylaminohydrolase inhibition and asymmetric dimethylarginine accumulation contribute to endothelial dysfunction in rats exposed to glycosylated protein: Effects of aminoguanidine. Atherosclerosis 2007 190 (1):53-61.7) Lu CW, Xiong Y (ÐÜÑ࣬ͨѶ×÷Õß), He P. Dimethylarginine dimethylaminohydrolase-2 overexpression improves impaired nitric oxide synthesis of endothelial cells induced by glycated protein. Nitric Oxide 2007 16(1): 94-103.8) Xiong Y (ÐÜÑà), Collins QF, Jie A, Lupo E Jr, Liu HY, Liu D, Robidoux J, Liu Z, Cao W. p38 mitogen-activated protein kinase plays an inhibitory role in hepatic lipogenesis. J Biol Chem. 2007 282(7):4975-82.9) Liu HY, Collins QF, Xiong Y (ÐÜÑà), Moukdar F, Lupo, Jr. EG, Liu Z, Cao W. Prolonged treatment of primary hepatocytes with oleate induces insulin resistance through p38 mitogen-activated protein kinase. J Biol Chem. 2007 282(19):14205-12.10) Collins QF, Xiong Y (ÐÜÑà), Lupo,Jr EG, Liu HY, Cao W. p38 Mitogen-activated protein kinase mediates free fatty acid-induced gluconeogenesis in hepatocytes. J Biol Chem 2006 281(34): 24336-44.11) Cao W, Collins QF, Becker TC, Robidoux J, Lupo, Jr. EG, Xiong Y (ÐÜÑà), Daniel KW, Floering L and Collins S. p38 Mitogen-activated Protein Kinase Plays a Stimulatory Role in Hepatic Gluconeogenesis. J. Biol. Chem. 2005 280 (52): 42731-7.12) Xiong Y (ÐÜÑ࣬ͨѶ×÷Õß), Lei M, Fu S, Fu Y. Effect of diabetic duration on serum concentrations of endogenous inhibitor of nitric oxide synthase in patients and rats with diabetes. Life Science 2005 77(2): 149-59.13) Yin QF, Xiong Y (ÐÜÑ࣬ͨѶ×÷Õß). Pravastatin restores DDAH activity and endothelium-dependent relaxation of rat aorta after exposure to glycated protein. J Cardiovas Pharmacol 2005 45(6): 525-32.14) Fu YF, Xiong Y (ÐÜÑ࣬ͨѶ×÷Õß), Guo Z. A reduction of endogenous asymmetric dimethylarginine contributes to the effect of captopril on endothelial dysfunction induced by homocysteine in rats. Eur J Pharmacol 2005 508(1-3):167-75.15) Deng HF, Xiong Y (ÐÜÑ࣬ͨѶ×÷Õß). Effect of pravastatin on impaired endothelium-dependent relaxation induced by lysophosphatidylcholine in rat aorta. Acta Pharmacol Sinica. 2005 26(1):92-8.16) Xiong Y (ÐÜÑ࣬ͨѶ×÷Õß), Fu YF, Fu SH, Zhou HH. Elevated levels of the serum endogenous inhibitor of nitric oxide synthase and metabolic control in rats with streptozotocin-induced diabetes. J Cardiovas Pharmacol 2003 42(2): 191-6.17) Fu YF, Xiong Y (ÐÜÑ࣬ͨѶ×÷Õß), Fu SH. Captopril restores endothelium-dependent relaxation of rat aortic rings after exposure to homocysteine. J Cardiovas Pharmacol 2003 42(4):566-72.18) Xiong Y (ÐÜÑ࣬ͨѶ×÷Õß), Lei MX, Fu SH, Fu YF. The changes in serum contents of endogenous nitric oxide synthase inhibitor in patients with type 2 diabetes. Diabetes Research and Clinical Practice 2002 56 (Suppl 1): S185-6.19) Xiong Y (ÐÜÑ࣬ͨѶ×÷Õß), Yuan LW, Deng HW, Li YJ, Chen BM. Elevation of serum endogenous inhibitor of nitric oxide synthase and endothelial dysfunction in aged rats. Clin Exper Pharmacol Physiol. 2001 28(10): 842-7.20) Xiong Y (ÐÜÑà), Ru R, Li YJ, Deng HW. Elevation of an endogenous inhibitor of nitric oxide synthase in diabetic rats. Acta Pharmacol Sinica. 1997 18(6): 511-4.21) Xiong Y (ÐÜÑà), Li YJ, Deng HW, Liu GZ, Li NS. Endogenous inhibitors of nitric oxide synthesis and lipid peroxidation in hypercholesterolemic rabbits. Acta Pharmacol Sinica 1996 17(2): 149-52.22) Yu XJ, Li YJ, Xiong Y (ÐÜÑà). Increase of an endogenous inhibitor of nitric oxide synthesis in serum of high cholesterol fed rabbits. Life Science 1994 54(12): 753-8.23) Xiong Y (ÐÜÑà), Li YJ, Deng HW. Protection of L-arginine against oxygen free radicals-injured rabbit aortic endothelium. Acta Pharmacol Sinica 1994 15(2): 119-23.